Tiny needle patch takes aim at skin cancer
Disease control
Recruiting now
This study tests a small adhesive patch with tiny needles that deliver a low dose of the chemotherapy drug doxorubicin directly into skin cancer tumors. It involves 48 people with squamous cell skin cancer who are either immune-competent or immune-suppressed. The goal is to see i…
Phase: PHASE1, PHASE2 • Sponsor: Falo, Louis, MD • Aim: Disease control
Last updated Jun 25, 2026 12:09 UTC